[Chronic, infantile, neurologic, cutaneous and articular syndrome (CINCA) in an infant]

B Milewska-Bobula1, B Lipka, K Rowecka-Trzebicka

  • 1Clinique du nourrisson, institut Monument, centre de santé de l'enfant, Varsovie, Pologne.

Insights

Chronic infantile neurological cutaneous and articular (CINCA) syndrome presents with multi-organ inflammation unresponsive to treatment. Diagnosis requires long-term observation and exclusion of other conditions.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Immunology

Background:

  • Covers the challenging diagnosis of CINCA syndrome, a chronic, multi-organ inflammatory condition with unknown causes.
  • Highlights its resistance to conventional therapies, posing significant clinical management hurdles.

Observation:

  • Presents a case of an 18-month-old boy with symptoms starting at 2 months.
  • Details the patient's cutaneous, articular, neurological, and ocular manifestations, alongside lymphadenopathy and hepatosplenomegaly.
  • Notes the ineffectiveness of anti-inflammatory drugs, antihistamines, and rehabilitation.

Findings:

  • CINCA syndrome is characterized by persistent, treatment-resistant inflammation affecting multiple organ systems.
  • Early childhood onset of symptoms is a key feature, necessitating careful differential diagnosis.

Implications:

  • Emphasizes the need for extended clinical monitoring for accurate CINCA syndrome diagnosis.
  • Stresses the importance of excluding other chronic inflammatory diseases in pediatric cases.
  • Informs clinical practice regarding the diagnostic challenges and long-term management considerations for CINCA syndrome.
Abstract